| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
June 09, 2011 |
|
|
| |
|
|
| |
|
|
|
Radisson Blu Scandinavia Hotel, Duesseldorf
10/30/2011
Topics - China Life Science Industry Landscape and Opportunities
- Accessing Government Support and Funding: What Are the Science Parks All About?
- Case Study: Cross Border Dealmaking from the Perspective of a Chinese Pharma
- Show Me the Money: An Overview of the Financing Landscape in China
- Practical Advice on Partnering in China: The Big Pharma Perspective
- Cheaper? Better? Faster? Overview of China's Contract Services Industry
- Growth Market China: Maximizing Value by Choosing the Right Products and Distribution Channels
- Dos and Don'ts of Protecting Intellectual Property Rights
- Navigating China's Regulatory Environment
- Executive Interview: A CEO’s Road to China
|
|
|
|
|
|
|
|
Organized by:
|
|
EBD Group |
|
|
Invited Speakers:
|
|
- Alicia Hong – Head of China Practice, WilmerHale
- Darren Ji – CEO, Pharma Legacy
- Kewen Jin – General Manager, Charles River Greater China
- Yuwen Liu – CEO, BioBay
- Greg B. Scott – President and Founder, ChinaBio® LLC
- Victor Shi – President, Asia Pacific, QIAGEN
- Dan Zhang – CEO, Fountain Medical Development
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
The registration fee will be EUR 250. BIO-Europe attendees will benefit from a EUR 100 discount on their registration for China Forum.
|
|
|
E-mail:
|
|
dtorrez@ebdgroup.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|